BKB Growth Investments, LLC 3

Accession 0002101167-26-000002

CIK 0001660334other

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 4:23 PM ET

Size

7.3 KB

Accession

0002101167-26-000002

Form 3

Period: 2025-11-25

10% Owner

Holdings

Common Stock
3,348,372
Series B Warrants (right to buy)
[F1][F2]
Exercise: $1.33Exp: 2029-11-22→ Common Stock (224,719 underlying)
Series C Warrants (right to buy)
[F1][F3]
Exercise: $6.32Exp: 2030-11-25→ Common Stock (687,690 underlying)

Footnotes (3)

[F1]Immediately exercisable.
[F2]The Reporting Person will not be entitled to exercise any portion of a Series B Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 19.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.
[F3]The Reporting Person will not be entitled to exercise any portion of a Series C Warrant that, upon giving effect to such exercise, would cause the aggregate number of shares beneficially owned by the Reporting Person to exceed 19.99% of the number of shares of the Issuer's common stock outstanding immediately after giving effect to the exercise.

Signature

BKB Growth Investments, LLC, By: Tiger Lily Capital, LLC, its manager By: /s/ Paul Manning, its manager|2026-01-26

Documents

1 file

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

IncorporatedDE